Maricel Apuli Bridge Bio Pharma, Inc. (BBIO) insider trading activity

Maricel Apuli is Chief Accounting Officer of BridgeBio Pharma, Inc.. Currently has a direct ownership of 128,294 shares of BBIO, which is worth approximately $8.52 Million. The most recent transaction as insider was on Dec 12, 2025, when has been sold 2,003 shares (Common Stock) at a price of $75.15 per share, resulting in proceeds of $150,525. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 128K

6.41% 3M change

n/a 12M change

Total Value Held $8.52 Million

Maricel Apuli Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 12 2025	SELL Payment of exercise price or tax liability	$150,525 $75.15 p/Share	2,003 Reduced 1.54%	128,294 Common Stock
Dec 08 2025	SELL Open market or private sale	$148,520 $74.26 p/Share	2,000 Reduced 1.51%	130,297 Common Stock
Nov 16 2025	SELL Payment of exercise price or tax liability	$317,410 $66.39 p/Share	4,781 Reduced 3.49%	132,297 Common Stock
Aug 16 2025	SELL Payment of exercise price or tax liability	$245,360 $51.32 p/Share	4,781 Reduced 3.37%	137,078 Common Stock
Aug 07 2025	SELL Open market or private sale	$45,440 $45.44 p/Share	1,000 Reduced 0.7%	141,859 Common Stock
May 16 2025	SELL Payment of exercise price or tax liability	$161,755 $33.84 p/Share	4,780 Reduced 3.24%	142,859 Common Stock
May 02 2025	SELL Open market or private sale	$39,511 $38.51 p/Share	1,026 Reduced 0.69%	147,639 Common Stock

Mar 19 2025	BUY Grant, award, or other acquisition	-	23,660 Added 13.73%	148,665 Common Stock

Maricel Apuli

Chief Accounting Officer

Palo Alto, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BBIO shares.

Notify only if

Value

Insider Trading

Get notified when an Bridge Bio Pharma, Inc. insider buys or sells BBIO shares.

Notify only if

Operation

Value

Type

News

Receive news related to BridgeBio Pharma, Inc.

Track Activities on BBIO

Account